PROVIDERS
Quality and accuracy are basics at Ambry, and we go beyond
Find the genetic testing, resources, and support you need to help guide patient care.
Testing and Specialty Areas
Our flexible testing options range from targeted panels, single genes, to broader approaches like exome sequencing. This helps you choose the right approach for each patient and specialty area.
Oncology
Peutz-Jeghers syndrome
Product
Neurology
Legius Syndrome
Product
Clinical Genomics
Shwachman-Diamond syndrome
Product
Oncology
Multiple endocrine neoplasia type 4
Product
Oncology
PALB2-associated cancer
Product
Oncology
Hereditary Mixed Polyposis Syndrome
Product
Clinical Genomics
Surfactant Dysfunction
Product
Clinical Genomics
Congenital central hypoventilation syndrome (CCHS)
Product
Oncology
PTEN-related Disorders
Product
Oncology
Adenomatous polyposis
Product
Neurology
Li-Fraumeni Syndrome
Product
Clinical Genomics
Multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC)
Product
Oncology
Peutz-Jeghers syndrome
Product
Oncology
Multiple endocrine neoplasia type 4
Product
Oncology
PALB2-associated cancer
Product
Oncology
Hereditary Mixed Polyposis Syndrome
Product
Oncology
PTEN-related Disorders
Product
Oncology
Adenomatous polyposis
Product
Oncology
BRCA1 and BRCA2
Product
Oncology
CHEK2-related Cancer
Product
Oncology
Hereditary Retinoblastoma
Product
Oncology
Familial adenomatous polyposis (FAP)
Product
Oncology
Pleuropulmonary blastoma and DICER1-related disorders
Product
Clinical Genomics
Hereditary Leiomyomatosis and Renal Cell Carcinoma
Product
Cardiology
ARVCNext™
Product
Cardiology
CPVTNext®
Product
Cardiology
FHNext®
Product
Cardiology
Other Lipid Disorders
Product
Cardiology
CMNext®
Product
Cardiology
CardioNext®
Product
Cardiology
CustomNext-Cardio®
Product
Cardiology
TAADNext®
Product
Cardiology
LongQTNext / RhythmNext®
Product
Cardiology
HCMNext®
Product
Cardiology
DCMNext®
Product
Clinical Genomics
Shwachman-Diamond syndrome
Product
Clinical Genomics
Surfactant Dysfunction
Product
Clinical Genomics
Congenital central hypoventilation syndrome (CCHS)
Product
Clinical Genomics
Multiple endocrine neoplasia type 2 (MEN2) and familial medullary thyroid cancer (FMTC)
Product
Clinical Genomics
Multiple endocrine neoplasia type 1 (MEN1)
Product
Clinical Genomics
Juvenile polyposis syndrome
Product
Clinical Genomics
von Hippel-Lindau disease
Product
Clinical Genomics
Hereditary Leiomyomatosis and Renal Cell Carcinoma
Product
Clinical Genomics
HHTNext®
Product
Clinical Genomics
NoonanNext
Product
Clinical Genomics
Primary ciliary dyskinesia (PCD)
Product
Clinical Genomics
RET-related Hirschsprung disease
Product
Neurology
Legius Syndrome
Product
Neurology
Li-Fraumeni Syndrome
Product
Neurology
Ataxia-Telangiectasia
Product
Neurology
Tuberous Sclerosis Complex
Product
Neurology
Neurofibromatosis 1
Product
Neurology
Schwannomatosis
Product
Neurology
Neurofibromatosis 2
Product
Neurology
Familial Hemiplegic Migraine
Product
Neurology
Fragile X-associated Disorders
Product
Neurology
Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome)
Product
Clinical Genomics
ExomeNext® and ExomeReveal®
Product
Neurology
EpilepsyNext ®
Product
Why Ambry
Quality and accuracy are foundational to genetic testing. Ambry goes further with dedicated support, scientific expertise, and a longstanding commitment to finding answers for patients and providers.
For over 25 years, we’ve combined innovation with a relentless pursuit to deliver clearer insights and informed care decisions.
For over 25 years, we’ve combined innovation with a relentless pursuit to deliver clearer insights and informed care decisions.
What to Expect
Billing Support
Our specialists help make genetic testing accessible and affordable by handling coverage, costs, and payment coordination.
Learn More
Family Studies
Helps clarify variants of uncertain significance (VUS) through follow-up testing of family members, offering meaningful clinical insights.
Learn More
Genomic Science Liaisons
A team of experts can help you interpret test results and consider how to apply them in patient care.
Learn More
RNA Studies
Available to help clarify uncertain results and provide insights beyond what DNA testing alone can show.
Learn more
Patient for Life Program
By reviewing results over time, we provide updated reports as new information becomes available, today and in the future.
Learn more
Selecting and Ordering Testing
AmbryPort simplifies choosing the right test and ordering, all while connecting you to the support and resources needed throughout the process.
Step
Send Sample to Ambry
Step
Ambry Completes Testing
Step
Results Available in AmbryPort
Additional Solutions
Ambry offers digital tools and programs to help you identify high-risk patients, support clinical workflows, and expand access to genetic testing that informs healthcare decisions.
The CARE Program®
CARE (Comprehensive Assessment Risk and Education) uses digital health tools to help you identify patients at increased risk for hereditary cancer and those eligible for genetic testing with educational resources, ordering, reporting, and genetic counseling support built into clinic workflows.
Progeny
Progeny is a software platform that helps teams manage family history, hereditary disease risk assessment, pedigree generation, reporting, and patient data across clinical and research genetics workflows.
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)